Under the auspices of the Organic Analysis Working Group (OAWG) of the Comité Consultatif pour la Quantité de Matière (CCQM) a laboratory comparison, CCQM-P20.f, was co-ordinated by the Bureau International des Poids et Mesures (BIPM) in 2007/2008. Nine national measurement institutes, four expert laboratories and the BIPM participated in the comparison. Participants were required to assign the mass fraction of digoxin present as the main component in the comparison sample (CCQM-P20.f) which consisted of digoxin material obtained from a commercial supplier stated to comply with USP requirements.
In addition to assigning the mass fraction content of digoxin for the material, participants were requested, but not obliged, to provide mass fraction estimates for the minor components they identified in each sample.
In contrast with the previous round of the CCQM-P20 series, in which the mass fraction content of theophylline in two comparison samples (CCQM-P20.e.1 and CCQM-P20.e.2) was determined, a wider range of results were reported for the mass fraction content of digoxin in the CCQM-P20.f comparison.
A minority of participants did not appear to use conditions capable of fully resolving and/or quantifying the major related structure impurities present in the comparison sample. Among those that did achieve suitable separations, there was further variation in their reported quantifications of the individual and total related substance content which reflected in part the limited availability of reference standards for these materials and the resulting assumptions that
Introduction
The OAWG meeting at Sèvres in April 2007 accepted the proposal by the BIPM to co-ordinate, in collaboration with the LGC, the continuation of the ongoing CCQM-P20 comparison investigating the characterization of organic substances for chemical purity. For this round, designated CCQM-P20.f, the LGC sub-divided a sample of purified digoxin, which was sourced from a commercial supplier and used as supplied, into individual units each containing 500 mg of the bulk material. The digoxin source material was stated by the supplier to "correspond with the requirements of current Ph. Eur.; JP; IP and USP". The individual units consisted of amber glass storage vials (5 ml capacity) which were sealed with an inert rubber insert and crimped with an aluminium cap. Two hundred units were shipped to the BIPM who investigated and, where possible, identified the minor components present in the material. The BIPM characterized the homogeneity and stability of all identified minor components of the material and shipped the material to the study participants. The mass fraction content of digoxin was assessed by the BIPM to be greater than 975 mg/g for the material, and the homogeneity and stability of the sample was confirmed to be suitable for the purposes of the comparison. The results reported by the study participants are the subject of this report. The CCQM-P20 comparison was undertaken initially for national metrology institutes interested in the assessment of the purity of organic compounds and followed on from the earlier CCQM-P5 (previously known as CCQM-6) study on the same topic. The overall purpose of the CCQM-P20 comparison is to investigate current practice for the assignment of mass fraction content to an organic compound intended for use as a primary standard or for the preparation of primary calibration solutions. The expected outcome of the study is to evaluate the scope, applicability, limitations and appropriateness of the various approaches and techniques used to assign purity property values to organic materials through a series of strategically planned exercises as well as to validate methods for use in planned CCQM Key Comparisons in this area. In previous rounds purity assignments were undertaken on tributyltin chloride (CCQM-P20.a), xylene (CCQM-P20.b), atrazine (CCQM-P20.c), chlorpyrifos (CCQM-P20.d) and theophylline (CCQM-P20.e.1 & CCQM-P20.e.2).
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Characterization of the comparison sample
Digoxin was selected for this round of the CCQM-P20 series because it:  is an important analyte in clinical chemistry, was not available as a pure substance Certified Reference Material at the commencement of the study and is of specific interest within the framework of ongoing activities of the Joint Committee on Traceability in Laboratory Medicine (JCTLM)  provided a significant analytical challenge and was representative of a structural class of organic compounds that had not been investigated in previous rounds  could be provided in an amount that permitted sufficiently detailed investigation
The structure of digoxin is shown in Figure 1 . The structures of a number of related compounds referred to in this report are shown in Annex 1. The compound provided without doubt the most significant analytical challenge thus far within the CCQM-P20 comparison series. Its size and structural complexity made it unsuitable for analysis by gas chromatography or differential scanning calorimetry. It was also the first CCQM-P20 analyte that contains centres of stereogenicity (chirality). As an indicator of one of the analytical challenges presented by digoxin, there are theoretically 2 21 (> 2 × 10 6 !) stereoisomers of digoxin and an even larger number of regioisomeric forms. In addition, aglycones and related structure glycones comprised of the digoxin aglycone (digoxigenin) attached to carbohydrate chains of different length and structure, were also known to be potentially present as impurities. Digoxin is a white crystalline powder with a reported melting point of 249 °C. It has limited solubility in water and alcoholic solvents and is sparingly soluble in non-polar organic solvents. It is a widely used medication for the treatment of various heart conditions that cannot be controlled by other medications. Adverse, potentially fatal, drug reactions are possible because of its narrow therapeutic index. As a result of its widespread use, narrow efficacy range and the potential for fatal adverse reactions, it is an important analyte in clinical testing programmes and in medical laboratory proficiency testing schemes. No high-purity certified reference material (CRM) for digoxin was available at the start of the comparison, although reference substances are available from the U.S. and European pharmacopoeias.
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Homogeneity studies
The homogeneity of the study material was assessed by use of two methods, both using high performance liquid chromatography and with either tandem mass spectrometry detection (LC-MS/MS) or diode array UV-detection (LC-UV). Both methods allowed for simultaneous determination of digoxin and a range of related structure steroid glycosides, but the LC-MS/MS method was more sensitive and displayed better repeatability compared to the LC-UV method. The uncertainty contributions due to the inhomogeneity of each analysed component was evaluated by an ANOVA approach. This approach provided an estimate of the variation due to inhomogeneity at a stated sampling size both between and with sample units. The inhomogeneity of the digoxin content of the material was estimated from combination of the individual assessments of the uncertainty contributions due to the between-bottle inhomogeneity of each of the minor components. Acceptable uncertainties due to within-unit and between-unit inhomogeneity were observed for the major component digoxin in the candidate study material when using the LC-UV method under repeatability conditions. Where minor components were identified and reference standards were available the more repeatable LC-MS/MS method was used to perform the homogeneity assessment. For unidentified impurities only the LC-UV method could be used for the homogeneity assessment. The study sample was assessed as being appropriate for use in CCQM-P20.f for the evaluation of inherent impurities present at mass fraction levels of 1 mg/g or higher when a sample size greater than 2.5 mg was used for analysis of the material. In four cases where authentic standards were available, an external calibration approach was used to provide the quantitative estimate of the amount of each identified minor component. External calibration should also have allowed for the detection of significant changes in homogeneity due to variations in the levels of other impurities such as water and residual organic solvent which are not directly determined by LC methods. The fact that no such significant change was observed with any of the materials assessed by external calibration indicated that there was also a suitable degree of homogeneity in these miscellaneous impurities within and between the sample batch units. Direct studies of the water content and residual organic solvent content of the material confirmed this assessment. One component, identified as β-acetyl digoxin, displayed a higher apparent level of inhomogeneity than the other minor components. This was ascribed to in situ hydrolysis and/or rearrangement of the acetyl substituent under the sample preparation and analysis conditions rather than inherent inhomogeneity within the study sample. To minimize the influence of breakdown of the β-acetyl digoxin component participants were advised to analyse solutions of the study sample as soon as possible after their preparation and to discard solutions that were more than 24 h old.
Stability studies
An isochronous stability study was performed using a reference storage temperature of −20 °C and test temperatures of 4 °C, 22 °C and 40 °C. Samples were stored at the selected temperatures over 8 weeks, with units transferred to reference temperature storage at 2-week intervals. Trend analysis of the data obtained by LC-UV analysis of the test samples indicated no significant change in composition of digoxin or of the minor UV-active components over this time at any of the test temperatures. The effect of temperature on water content (as measured by Karl Fischer assay) and volatile organic content (as measured by GC-MS analysis), which together made up the major non-UV active impurities found by the co-ordinating laboratory in the sample, was also investigated. No significant changes were observed after storage at 4 °C or 22 °C. There was evidence of a reduction in volatile organic content after prolonged storage at 40 °C. On the basis of these studies it was concluded that the material was suitably stable for short-term transport at ambient temperature, provided the sample was not exposed to temperatures in excess of 40 °C, and for longer term storage at 4 °C. Consistent with the results of the homogeneity study, there was apparent evidence of instability in the case of the minor component β-acetyl digoxin but this was ascribed to partial hydrolysis under the conditions used for LC-UV analysis, as observed previously for the homogeneity study, rather than instability of the material.
Sample distribution
One unit of the study sample, containing a minimum of 500 mg of material, was distributed to each participant. Participants were asked to sign and return a form acknowledging receipt of the samples and to advise the co-ordinator if any damage had occurred to the container or the vials containing the study samples during shipping. Recipients were also asked to confirm that a monitoring strip inside the shipping container had not registered a temperature in excess of 37 °C during the transport process. No problems were reported with any of the comparison samples.
Quantities and Units
Participants were required to report the mass fraction of the major component, digoxin, in both materials. It was recognized that some measurement methods could provide purity estimates expressed as related quantities (e.g. amount of substance fraction) but study participants were asked to correct their results in this event.
The units for reporting the mass fraction content of digoxin were mg/g.
Participants were encouraged to provide, where possible, mass fraction estimates for the minor components of the materials. The ability to identify and quantify minor components is regarded as an important competency for the high-level characterization of organic materials.
Recommended Minimum Sample Size
Investigations at BIPM of the homogeneity of digoxin identified a minimum sampling size for each material which reduced to an acceptable level the effect of within-bottle and between-bottle inhomogeneity. The recommended minimum sample size was 2.5 mg per analysis replicate. Compliance with this recommendation was important for participants using a mass balance or summation of impurities (100-x) method to determine digoxin content, or those who wished to quantify the mass fractions of the minor components of each material.
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Reported Mass Fraction Content of Digoxin in CCQM-P20.f
The estimates reported by the study participants for digoxin content of CCQM-P20.f are summarized in Table 1 and plotted in Figure 2 . USP reported results for the materials using both a USP Digoxin Assay and a USP Digoxin Related substances assay. The estimates reported by the study participants for digoxin content of CCQM-P20.f are summarized in Table 1 and plotted in Figure 2 . All but two participants used a formal mass balance approach based on high-performance liquid chromatographic separation of the digoxin from related structure impurities with supporting methods for other classes of impurity to obtain an estimate of the total impurity content, and by subtraction the mass fraction content of digoxin. The DGKL reported the digoxin content based solely on the total related structure impurity content as quantified by HPLC-UV and explicitly noted that this value would overestimate the digoxin content if a significant level of impurities not detectable by LC-UV were present. The NRC-INMS was the only participant to rely solely on quantitative nuclear magnetic resonance (QNMR) to assign the digoxin content. However other participants used NMR as a contributing method to their overall characterization and two explicitly noted that due to the complex profile of related structure impurities in the sample it was not possible to identify a NMR signal that was unique to digoxin and therefore they could not obtain a reliable QNMR estimate of digoxin content by this approach. A contribution due to an undetected overlap of the digoxin signal selected for quantification with signal(s) due to one or more impurities of related structure may explain the relatively high value for digoxin content reported by NRC-INMS. 
Figure 2
Mass fraction of Digoxin in CCQM-P20.f material (with expanded uncertainties)
Method Summaries and Measurement Equations Lab ID Measurement Equation Method Summary

NMIA
Digoxin (mg/g) = (100 %-I "HPLC-all" ) × (100%-I OT ) × 10 I HPLC-all = (R HPLC-raw × I HPLC-raw ) + I NR + I ND Where: I HPLC-all = total impurities by HPLC (percentage of normalized LC-UV response) assuming identical UV response factors R HPLC-raw = relative response factor of total impurities (assumed to be 1.0 with associated uncertainty) I HPLC-raw = total impurities (%) from LC-UV data I NR = allowance for non-resolved impurities I ND = allowance for impurities below detection limit I OT = impurities not detectable by LC-UV I HPLC-raw derived from normalized LC/UV peak area responses at 238 nm, solution conc. 2000 μg/ml. I OT from water content by Karl Fischer titration and organic solvent impurities by 1 H NMR for thermogravimetric analysis (TGA) and elemental microanalysis were used to control the consistency of the result. 1 H NMR, elemental microanalysis and TGA were used to control the overall results.
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mass (in g) of components in the test sample not quantified by LC-UV. For P20.f these included related impurities quantified by LC-MS, water content by Karl Fischer titration and organic solvents quantified by GC-MS.
Normalized UV peak area of digoxin R i = UV response factor (on a mass basis) of component i relative to digoxin NOTE: Mass fraction (mg/g) of digoxin in P20.f sample = 1000 
D w
The LC-UV peak area responses at 215 nm were used with a correction applied to take account of UV response factors relative to digoxin. Where minor components were identified by comparison with authentic standards and could be quantified by LC-MS, the LC-MS value was used in preference to the less sensitive and less selective LC-UV data. A correction for water content by Karl Fischer titration and residual solvent by GC-MS was also applied to the LC-UV data. 1 H NMR, elemental microanalysis and TGA were used to confirm no significant impurity sources had been overlooked.
NIST
Area 1 mg 1000 sample g digoxin mg mg IC absolute = mass in mg of impurity components is the mass in mg of known impurity components determined relative to mass of sample (here, the inorganic and identified glycoside impurities), Area IC and Area digoxin are the peak areas of the impurity and digoxin, RF IC and RF digoxin are the molar response factors for the impurity and digoxin, and MM IC and MM digoxin are the molar masses for the impurity and digoxin. For 1H NMR assignments, the RF IC s are proportional to the number of equivalent hydrogens. For LC/UV 220 assignments, the RF IC s are assumed to follow the distribution of the RFs determined for glycoside standards. The molar masses of the unidentified glycoside impurities were assumed to follow a distribution defined by the molar mass of digoxin and the available evidence for the minimum number of sugar moieties present. LGC 
NIMT
From normalized LC-UV peak area response at 217 nm., after correction for water content. The above uncertainty components were evaluated via Monte Carlo propagation of uncertainty estimates for individual impurity components. The individual component uncertainties were determined by repeated experiment and/or expert opinion for identified impurities. They were extrapolated from experimental evidence and expert opinion for the unidentified chromatographic peaks. (1) Uncertainty of individual impurities assessed with the formula. 
NMIJ
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DGKL
Major components of uncertainty: 1) Dispersion of peak area measurements  calculated from 5 repetitive measurements 2) Response factors for the recording in a range from 200 nm to 240 nm  Since the identity of the minor components is not known, the response factors have been set to =1.
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Impurity Profile of CCQM-P20.f
All submissions except the NRC QNMR report provided information on the minor components (impurity content) of the study material. As was to be expected given the biological origin and complex structure of digoxin, which is prepared commercially by purification of plant extract obtained from the digitalis species, numerous significant (> 0.1 % by relative LC-UV response) related structure impurities were present in the study sample. A representative chromatogram of the digoxin comparison sample (reproduced from the USP submission) with structural assignments of the minor components identified by the USP is shown in Figure 3 .
Figure 3 Representative LC-UV chromatogram for CCQM-P20.f
Compounds identified in the comparison material by more than one participant included digitoxin, gitoxin, digoxigenin, β-acetyl digoxin and digoxigenin tetradigitoxide. Participants who identified some of the minor components reported in addition the presence of several unidentified UV-active materials. These impurities were all assumed to be steroid glycosides of related structure, either on the basis of the similarity of their UV spectra to that of digoxin or on LC-MS evidence or both. NIM made tentative structural assignments of a number of these components based on MS data and USP identified more of the minor components than any other participant through comparison with authentic standards. Several participants (NMIA, NIST, BIPM, NIM, NMIJ, LGC) used analysis by LC-MS as well as LC-UV to provide further qualitative and quantitative information on the impurity content. The total UV-active impurities, with structural assignments where available, by participant are given in Table 2 . Several participants provided a listing, by elution time relative to the main component, of the main resolved impurities. A comparative summary of these impurities with identification and quantification where available, is given in 
LC-UV @ 238 nm. Identity by LC-MS
Other impurity components identified in CCQM-P20.f included water (quantified directly by Karl Fischer titration or as a component of total volatiles by loss-on-drying measurements) and residual organic solvents (identified directly by GC-MS or NMR or as a component of total volatiles by loss-on-drying measurements). The results reported by each participant are summarized in Table 4 . NIST reported that loss-on-drying methods only measured water content of the material and did not in this case provide information on the residual solvent content. They observed that their headspace GC estimates for residual solvent did not alter after extensive preliminary drying of the material at 105 °C. This conclusion is supported by the observation that thermogravimetric analysis, carried out separately by NMIA, BIPM and NMIJ, also failed to detect significant volatile content. Estimates for total inorganic content of the material were obtained using X-ray fluorescence spectrometry (NIST), ICP-OES (LGC) or by residue after ignition (MP). 
Reference Value for Digoxin in CCQM-P20.f
An assignment of a reference value for the digoxin content of CCQM-P20.f based on the study results as a whole did not appear to be justified. There is evidence of a bias in some of the submissions due to incomplete resolution of related substance impurities from the main component peak, and in most of the results due to insufficient allowance for the significant levels of organic solvent residues present in the sample. Several participants independently confirmed in follow-up studies undertaken after circulation of the study results that ethanol and dichloromethane were present in the sample at the levels reported by NIST and BIPM. NIST demonstrated that these components were not measured by simple loss on drying methods or other techniques for estimating total volatile content, but required use of a more selective test such as GC-MS or NMR. When these latter methods were used, good agreement was found between the estimates obtained for residual ethanol, dichloromethane and toluene in the study sample. Following the initial discussion of the results at the April 2008 meeting of the CCQM OAWG, the study co-ordinator was asked to propose a mass fraction content with associated uncertainty for the digoxin content of the CCQM-P20.f study sample based on summation of a "consensus estimate" for each of the independent classes of impurities identified in the comparison material derived from the ensemble of results submitted by the comparison participants. The calculation of the proposed value was discussed at the November 2008 OAWG meeting and approval was given to assign a reference value for the comparison based on this approach. Four orthogonal classes of impurity were detected in the CCQM-P20.f study sample:
 structurally related compounds  water  volatile organic solvent The measurement equation (1) The standard uncertainty associated with the mass fraction estimate was calculated from equation (2):
Consensus Estimates of Individual Impurity Classes
1.
Related Structure components There was reasonable agreement between most participants as to the identity and amount of UVactive impurities, despite the complex nature of the related substance impurities present in the study sample and the difficulties they posed for LC-UV analysis. The estimates for total UVactive impurities by participant are given in Table 2 and are plotted in Figure 4 below. In the absence of evidence of obvious outliers or significant difference between the mean and median, the participant mean was used as the estimate of the related structure impurity content and the standard deviation of the mean for the eleven submissions as the standard uncertainty associated with this value. 
2.
Water content Only the results obtained by participants using methods that provide a direct measurement of water content -Karl Fischer titration or NMR -were used to assign an overall estimate for the water content of CCQM-P20.f. The mass fraction estimates for water content reported by each participant using these techniques are summarized in Table 4 and plotted in Figure 5 . The median value (1.3 mg/g) was selected as the water content best estimate Water w . Given the relatively wide variation in results and the limited amount of data used to assign each value, most participants relied on only one or two data points to make their assignment. The robust standard deviation (MADe) (rather than the robust standard deviation of the mean, MADe/√n) was selected as a more appropriate estimate of the associated standard uncertainty. 
Volatile solvent content
Two participants identified the presence of ethanol, chloroform and toluene residues in the material at significant levels. The presence of these impurities was confirmed in characterization information provided by the source material supplier. A third laboratory identified chloroform only. The mass fraction estimates for solvent residues reported by each participant are also summarized in Table 4 . For calculation purposes the mean value of the reported results and the more conservative uncertainty estimate for each contributor were used to obtain the estimates of w Org Solv . and its associated standard uncertainty. 
4.
Non-volatiles/inorganic residues Participants investigated a variety of methods (TGA, ash residue, elemental microanalysis) for obtaining a global estimate of non-volatile content of the study sample but none detected significant levels (< 0.3 % on a relative mass fraction basis) of this general class of impurity. Two participants used more sensitive methodologies (XRF spectrometry, ICP-OES) that were able to detect and provide quantitative estimations for some individual inorganic components. The mass fraction estimates for inorganic materials present at greater than 0.1 mg/g are reported as the final entries in Table 4 . Given the lack of evidence from other techniques for the presence of total non volatile components at greater than 0.3 mg/g, the mass fraction estimate for contributions due to this class of impurity was assigned as a rectangular distribution in the range 0.1 mg/g to 0.3 mg/g. This gives the following assigned values for calculation purposes:
5.
Homogeneity factor The uncertainty contribution due to inhomogeneity of the total impurity content of the material was estimated at equivalent to 0.16 mg/g, based on the results of single factor ANOVA analyses of each of the UV-active impurities present in the material, obtained from homogeneity studies by LC-UV of the study material undertaken during the material characterization.
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Digoxin content reference value assignment
The values assigned from the combined results to the four classes of impurities are: When substituted into the equations (1) and (2) Figure 6 shows the individual participant results plotted against the proposed reference value (solid red line) and its associated expanded uncertainty corresponding to a 95 % coverage range (dashed red lines). The expanded uncertainty was calculated from the combined standard uncertainty estimate of 1.0 mg/g using a coverage factor (k) of 2. Figure 7 shows the difference of the participant results from the reference value (D i ) where:
The expanded uncertainty U i at the 95 % coverage level of the difference from the reference value was calculated for each result as: 
SUMMARY
In part, this disparity was expected given the significantly greater analytical challenge posed by digoxin which is structurally more complex, contained a wider variety of impurities and exhibited a lower sensitivity for detection by either UV or MS techniques than the CCQM-P20.e measurands. This was reflected in a bimodal distribution of the estimates for related structure impurity content.
A minority of participants did not appear to use conditions capable of fully resolving and/or quantifying the major related structure impurities present in the comparison sample. Among those that did achieve suitable separations, there was further variation in their reported quantifications of the individual and total related substance content which reflected in part the limited availability of reference standards for these materials and the resulting assumptions that had to be made regarding the structure and response factors relative to digoxin for each individual impurity. This was particularly relevant because of the span of molecular masses of the impurities present in the sample, which ranged from aglycones to glycones with tetrameric carbohydrate chains, relative to that of digoxin.
A significant additional factor also contributed to the observed variation of results. Unlike the CCQM-P20.e samples, in which the major impurities were solely related structure organic compounds, the CCQM-P20.f study material contained significant levels of residual organic solvents (ethanol, dichloromethane and to a lesser extent toluene). The majority of participants failed to detect and allow for the presence of this class of impurity, introducing a bias towards overestimation of digoxin content in most of the individual results.
However, the uncertainty budgets produced by several participants were sufficiently conservative such that their reported results were nevertheless consistent with the reference value for digoxin content assigned using a consensus mass balance approach.
The results of the comparison reinforces the conclusion from previous rounds of the CCQM-P20 study that care in developing and validating the suitability of the chromatographic separation method used to resolve the main component from the related structure impurities present is essential to obtaining reliable, comparable results when using the mass balance approach to estimate purity.
This specific comparison has demonstrated that, in addition to developing an appropriate chromatographic separation, it is also important to use complementary techniques capable of detecting all potential orthogonal classes of impurities if it is desired to demonstrate a general capability to assign purity with a small (< 0.2 % relative) standard uncertainty. 
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